Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects



Rating:

Share or cite this content

Citations should be made in the following way:
F. Trinkmann (Heidelberg, Germany), A. Reif (Heidelberg, Germany), M. Müller (Heidelberg, Germany), F. Trudzinski (Heidelberg, Germany), N. Kahn (Heidelberg, Germany), F. Herth (Heidelberg, Germany). Small airway disease in symptomatic convalescents after SARS-CoV-2 infection. 969

Member's Comments

No comment yet.

Related content which might interest you: Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005 The prevelance of respiratory infections in vaccined patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011 Management of chronic airway infection in bronchiectasis Source: Virtual Congress 2020 – The future of bronchiectasis management Year: 2020 Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005 Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 221s Year: 2002 Chlamydophila spp. infection in horses with recurrent airway obstruction shows similarities to human chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019 Year: 2019 Impact of viruses on airway diseases Source: Eur Respir Rev 2005; 14: 57-61 Year: 2005 Prevalence of coexistent airways obstruction in patients with cardiac disease Source: Eur Respir J 2004; 24: Suppl. 48, 278s Year: 2004 Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 Exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2007; 29: 1224-1238 Year: 2007 Impact of chronic bronchial infection on the lungs and beyond Source: Eur Respir Monogr 2013; 60: 46-57 Year: 2013 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002